Streetbeat News

Regulatory

GSK

GSK has announced the results from the first-ever efficacy trial of Shingrix (Recombinant Zoster Vaccine or RZV) in China. The Phase IV trial, which involved nearly 6,000 participants aged 50 years and above, showed that the vaccine's efficacy was up to 97%.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 11:10 am

ALPMF

PFE

The FDA has granted priority review to Pfizer and Astellas Pharma's XTANDI for non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence. This could potentially expedite the drug's approval process.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 10:47 am

FXI

China's President Xi Jinping, at the BRICS summit, has called for further expansion of cooperation in artificial intelligence. He emphasized the need to improve the safety, reliability, availability, and fairness of AI technology.

Portfolio Pulse from Charles Gross

August 23, 2023 | 10:30 am

EVTV

Envirotech Vehicles has received a notice from Nasdaq due to a delay in filing its Form 10-Q. The company is required to submit a plan within 60 days to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 10:24 am

BNOX

Bionomics has completed the last patient visit in its Phase 2 Attune study of BNC210 for Post Traumatic Disorder Stress. Topline results are expected by the end of September 2023. An end-of-phase 2 meeting with the FDA has been scheduled for September 2023 to review results from the Phase 2 PREVAIL study in patients with Social Anxiety Disorder and to obtain feedback on a proposed Phase 3 registrational program.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 10:07 am

SPY

VGK

Russian President Putin, at the BRICS meeting, stated that Russia's actions in Ukraine are aimed at ending the war which, according to him, was started by the West. He emphasized that Russia seeks a peaceful and justifiable settlement.

Portfolio Pulse from Charles Gross

August 23, 2023 | 9:57 am

TSLA

Tesla Inc. (NASDAQ:TSLA) has reportedly asked the National Highway Traffic Safety Administration (NHTSA) to withhold specific details about the use of its driver-assistance software in cars involved in crashes, citing confidential business information. The NHTSA has been investigating Tesla's Autopilot system following 30 crashes that resulted in 10 fatalities between 2016 and 2021. The Department of Justice (DOJ) is also conducting a criminal investigation into the matter.

Portfolio Pulse from Benzinga Neuro

August 23, 2023 | 9:36 am

TMPO

Tempo Automation has received a Nasdaq notification of noncompliance due to a delay in its Form 10-Q filing. The company has until October 16, 2023, to submit a plan to regain compliance with the Periodic Filing Rule.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 9:32 am

META

Elon Musk has criticized Meta Platforms Inc. (formerly Facebook) for manipulating the public globally and refusing to open source their algorithm. This criticism was in response to a post revealing Meta's sponsorship of activists to censor opponents during a national referendum. Musk has previously voiced concerns about Meta and its operations.

Portfolio Pulse from Benzinga Neuro

August 23, 2023 | 9:20 am

FXI

XIACF

China's Xiaomi has received approval from the state planner to manufacture electric vehicles (EVs). The company plans to start making cars by early next year.

Portfolio Pulse from Charles Gross

August 23, 2023 | 9:02 am